Introduction MiaMed, Inc. is a pharmaceutical company based in the United States and is a part of Amicus Therapeutics, Inc. The company is led by CEO Michael Jasulavic. In July 2016, Amicus Therapeutics, Inc. acquired MiaMed, Inc. for a sum of $89.41 million. |